Hypertrophic Cardiomyopathy with Septal Alcohol Ablation: A Case Report

Authors

  • Carolina Burigo Milanez Universidade do Extremo Sul Catarinense
  • Valentina Tiscoski Saavedra Universidade do Extremo Sul Catarinense
  • Maria Eduarda Dandolini Universidade do Extremo Sul Catarinense
  • Maria Fernanda dos Santos Corrêa Universidade do Extremo Sul Catarinense
  • Rafaela Zanatta Ferreira Universidade do Extremo Sul Catarinense
  • Amanda Cirimbelli Bolan Universidade do Extremo Sul Catarinense

DOI:

https://doi.org/10.18616/inova.v16i1.10591

Abstract

Hypertrophic cardiomyopathy is a genetically determined condition characterized by left ventricular hypertrophy without another cause that justifies the increased wall thickness. The disease affects approximately 0.2% of the adult population and can manifest in patients ranging from asymptomatic to advanced heart failure and sudden cardiac death. Its diagnosis is based on imaging exams, especially transthoracic echocardiography, complemented by magnetic resonance imaging. Treatment aims to control intravascular volume through pharmacological and behavioral measures and, in severe cases, invasive procedures such as percutaneous septal alcohol ablation. This study describes the case of a 67-year-old male patient, former smoker, who was diagnosed with hypertrophic cardiomyopathy in 2001 following a routine electrocardiogram and confirmation by transthoracic echocardiography. He began medical therapy and, over the years, underwent cardiac catheterization, septal alcohol ablation (2012), and coronary stent placement (2021). Currently, the patient presents with progressive dyspnea, occasional need for home oxygen, and multiple comorbidities, including GOLD group E Chronic Obstructive Pulmonary Disease and New York Heart Association class IV functional status. An individualized and coordinated approach is essential to optimize clinical outcomes and preserve patient functionality. Despite existing knowledge, gaps remain in understanding the disease, highlighting the need for further studies to improve management strategies, prevent complications, and enhance patient care.

Downloads

Download data is not yet available.

Published

2026-02-23